Ho ricevuto diverse richieste su cosa sia la terapia chelante.
Chelation therapy is used as a treatment for acute mercury, iron (including in cases ofthalassemia), arsenic, lead, uranium, plutonium and other forms of toxic metal poisoning.
The chelating agent may be administered intravenously, intramuscularly, or orally, depending on the agent and the type of poisoning.
One example of successful chelation therapy is the case of Harold McCluskey, a nuclear worker who became badly contaminated with americium in 1976. He was treated with diethylene triamine pentaacetic acid (DTPA) over many years, removing 41 MBq (1.1 mCi) of americium from his body. His death, 11 years later, was from unrelated causes.
Several chelating agents are available, having different affinities for different metals. Common chelating agents include:
Alpha lipoic acid (ALA)
Aminophenoxyethane-tetraacetic acid (BAPTA)
Deferasirox
Deferiprone
Deferoxamine
Diethylene triamine pentaacetic acid (DTPA)
Dimercaprol (BAL)
Dimercapto-propane sulfonate (DMPS)
Dimercaptosuccinic acid (DMSA)
Ethylenediamine tetraacetic acid (calcium disodium versante) (CaNa2-EDTA)
Ethylene glycol tetraacetic acid
D-penicillamine
Medically diagnosed heavy metal poisoning
Some common chelating agents are EDTA (ethylenediaminetetraacetic acid), DMPS (2,3-dimercaptopropanesulfonic acid), TTFD (thiamine tetrahydrofurfuryl disulfide), and DMSA (2,3-dimercaptosuccinic acid).
Calcium-disodium EDTA and DMSA are only approved for the removal of lead by the Food and Drug Administration while DMPS and TTFD are not approved by the FDA.
These drugs bind to heavy metals in the body and prevent them from binding to other agents.
They are then excreted from the body. The chelating process also removes vital nutrients such as vitamins C and E, therefore these must be supplemented.
Io non sono un medico, ma posso riportarvi notizie al riguardo prese da http://www.news-medical.net/health/Chelation-Therapy-Medical-Use.aspx.
Spero di esservi stata d'aiuto!
La terapia chelante è usata come trattamento per mercurio acuto, ferro (anche nei casi di talassemia), arsenico, piombo, uranio, plutonio e altre forme di avvelenamento da metalli tossici.
L'agente chelante può essere somministrato per via endovenosa, intramuscolare, o per via orale, a seconda dell'agente e del tipo di avvelenamento.
Un esempio di terapia chelante di successo è il caso di Harold McCluskey, un operaio nucleare che si è contaminato con americio nel 1976. E 'stato trattato con dietilene triamine pentaacetico acido (DTPA) per molti anni, ed sono stati rimossi 41 MBq (1.1 mCi) di americio dal suo corpo. La sua morte, 11 anni dopo, è stato per cause non correlate.
Diversi agenti chelanti sono disponibili, aventi differenti affinità per metalli diversi. Comuni agenti chelanti comprendono:
L'acido alfa lipoico (ALA)
Aminophenoxyethane-tetraacetico (BAPTA)
Deferasirox
deferiprone
deferoxamina
Dietilenico acido triamine pentaacetico (DTPA)
Dimercaprol (BAL)
Dimercapto-propano sulfonato (DMPS)
Dimercaptosuccinico acido (DMSA)
Etilendiammina tetraacetico (calcio disodico Versante) (CaNa2-EDTA)
Glicole etilene acido tetraacetico
D-penicillamina
Alcuni agenti sono comuni chelanti EDTA (acido etilendiamminotetraacetico), DMPS (2,3-dimercaptopropanesulfonic acido), TTFD (tiamina disolfuro tetraidrofurfurilico), e DMSA (2,3-dimercaptosuccinico acido).
Calcio-disodico EDTA e DMSA sono previsti solo per la rimozione del piombo dalla Food and Drug Administration, mentre il DMPS e TTFD non sono approvati dalla FDA.
Questi farmaci si legano ai metalli pesanti nel corpo e impedire loro di legarsi ad altri agenti.
Vengono poi espulsi dal corpo. Il processo di chelante rimuove anche sostanze nutrienti vitali come le vitamine C ed E, quindi questi devono essere integrate.
Chelation therapy is used as a treatment for acute mercury, iron (including in cases ofthalassemia), arsenic, lead, uranium, plutonium and other forms of toxic metal poisoning.
The chelating agent may be administered intravenously, intramuscularly, or orally, depending on the agent and the type of poisoning.
One example of successful chelation therapy is the case of Harold McCluskey, a nuclear worker who became badly contaminated with americium in 1976. He was treated with diethylene triamine pentaacetic acid (DTPA) over many years, removing 41 MBq (1.1 mCi) of americium from his body. His death, 11 years later, was from unrelated causes.
Several chelating agents are available, having different affinities for different metals. Common chelating agents include:
Alpha lipoic acid (ALA)
Aminophenoxyethane-tetraacetic acid (BAPTA)
Deferasirox
Deferiprone
Deferoxamine
Diethylene triamine pentaacetic acid (DTPA)
Dimercaprol (BAL)
Dimercapto-propane sulfonate (DMPS)
Dimercaptosuccinic acid (DMSA)
Ethylenediamine tetraacetic acid (calcium disodium versante) (CaNa2-EDTA)
Ethylene glycol tetraacetic acid
D-penicillamine
Medically diagnosed heavy metal poisoning
Some common chelating agents are EDTA (ethylenediaminetetraacetic acid), DMPS (2,3-dimercaptopropanesulfonic acid), TTFD (thiamine tetrahydrofurfuryl disulfide), and DMSA (2,3-dimercaptosuccinic acid).
Calcium-disodium EDTA and DMSA are only approved for the removal of lead by the Food and Drug Administration while DMPS and TTFD are not approved by the FDA.
These drugs bind to heavy metals in the body and prevent them from binding to other agents.
They are then excreted from the body. The chelating process also removes vital nutrients such as vitamins C and E, therefore these must be supplemented.
Commenti
Posta un commento